Status:
NOT_YET_RECRUITING
Clinical and Radiographic Evaluation of Hyaluronic Acid (Gengigel Teething) Versus Mineral Trioxide Aggregate( Angelus) as Pulpotomy Agent in Vital Primary Molars
Lead Sponsor:
Cairo University
Conditions:
Pulpotomies Primary Teeth
Pulp Disease, Dental
Eligibility:
All Genders
4-8 years
Phase:
PHASE1
Brief Summary
The goal of this clinical trial is to Clinical and Radiographic Evaluation of Hyaluronic Acid (Gengigel Teething) Versus Mineral Trioxide Aggregate( Angelus) as Pulpotomy Agent in Vital Primary Molars...
Detailed Description
Preservation of primary dentition decreases the risk of developing any occlusal abnormalities caused by premature loss of primary teeth, which are considered natural space maintainers for the successo...
Eligibility Criteria
Inclusion
- Patients:
- Aged 4-8 years, in good general health and medically within normal.
- Teeth:
- Restorable mandibular primary molars.
- History of reversible pulpitis.
- Pre-operative Radiographic criteria:
- Absence of periapical or inter-radicular radiolucencies.
- Absence of widening of periodontal ligaments (PDL) space.
- Absence of internal or external root resorption.
Exclusion
- Patients:
- With systemic disorders.
- Physical or mental disabilities.
- Unable to attend follow- up visits.
- Refusal of Participation.
- Refusal to sign the informed consent.
- Teeth:
- Previously accessed teeth.
- Mobile mandibular primary molars.
- Swelling in the vestibule or on palpation.
- Pain on percussion
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06611631
Start Date
March 1 2025
End Date
April 1 2026
Last Update
November 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt